Sanjiv J Shah1, Daniel H Katz2, Senthil Selvaraj2, Michael A Burke2, Clyde W Yancy2, Mihai Gheorghiade2, Robert O Bonow2, Chiang-Ching Huang2, Rahul C Deo1. 1. From the Division of Cardiology, Department of Medicine (S.J.S., D.H.K., S.S., M.A.B., C.W.Y., M.G., R.O.B.), Feinberg Cardiovascular Research Institute (S.J.S.), and Center for Cardiovascular Innovation (M.G., R.O.B.), Northwestern University Feinberg School of Medicine, Chicago, IL; Zilber School of Public Health, University of Wisconsin, Milwaukee (C.-C.H.); and Division of Cardiology, Department of Medicine, Institute for Human Genetics, California Institute for Quantitative Biosciences, and Cardiovascular Research Institute, University of California, San Francisco (R.C.D.). sanjiv.shah@northwestern.edu rahul.deo@ucsf.edu. 2. From the Division of Cardiology, Department of Medicine (S.J.S., D.H.K., S.S., M.A.B., C.W.Y., M.G., R.O.B.), Feinberg Cardiovascular Research Institute (S.J.S.), and Center for Cardiovascular Innovation (M.G., R.O.B.), Northwestern University Feinberg School of Medicine, Chicago, IL; Zilber School of Public Health, University of Wisconsin, Milwaukee (C.-C.H.); and Division of Cardiology, Department of Medicine, Institute for Human Genetics, California Institute for Quantitative Biosciences, and Cardiovascular Research Institute, University of California, San Francisco (R.C.D.).
Abstract
BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous clinical syndrome in need of improved phenotypic classification. We sought to evaluate whether unbiased clustering analysis using dense phenotypic data (phenomapping) could identify phenotypically distinct HFpEF categories. METHODS AND RESULTS: We prospectively studied 397 patients with HFpEF and performed detailed clinical, laboratory, ECG, and echocardiographic phenotyping of the study participants. We used several statistical learning algorithms, including unbiased hierarchical cluster analysis of phenotypic data (67 continuous variables) and penalized model-based clustering, to define and characterize mutually exclusive groups making up a novel classification of HFpEF. All phenomapping analyses were performed by investigators blinded to clinical outcomes, and Cox regression was used to demonstrate the clinical validity of phenomapping. The mean age was 65±12 years; 62% were female; 39% were black; and comorbidities were common. Although all patients met published criteria for the diagnosis of HFpEF, phenomapping analysis classified study participants into 3 distinct groups that differed markedly in clinical characteristics, cardiac structure/function, invasive hemodynamics, and outcomes (eg, phenogroup 3 had an increased risk of HF hospitalization [hazard ratio, 4.2; 95% confidence interval, 2.0-9.1] even after adjustment for traditional risk factors [P<0.001]). The HFpEF phenogroup classification, including its ability to stratify risk, was successfully replicated in a prospective validation cohort (n=107). CONCLUSIONS: Phenomapping results in a novel classification of HFpEF. Statistical learning algorithms applied to dense phenotypic data may allow improved classification of heterogeneous clinical syndromes, with the ultimate goal of defining therapeutically homogeneous patient subclasses.
BACKGROUND:Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous clinical syndrome in need of improved phenotypic classification. We sought to evaluate whether unbiased clustering analysis using dense phenotypic data (phenomapping) could identify phenotypically distinct HFpEF categories. METHODS AND RESULTS: We prospectively studied 397 patients with HFpEF and performed detailed clinical, laboratory, ECG, and echocardiographic phenotyping of the study participants. We used several statistical learning algorithms, including unbiased hierarchical cluster analysis of phenotypic data (67 continuous variables) and penalized model-based clustering, to define and characterize mutually exclusive groups making up a novel classification of HFpEF. All phenomapping analyses were performed by investigators blinded to clinical outcomes, and Cox regression was used to demonstrate the clinical validity of phenomapping. The mean age was 65±12 years; 62% were female; 39% were black; and comorbidities were common. Although all patients met published criteria for the diagnosis of HFpEF, phenomapping analysis classified study participants into 3 distinct groups that differed markedly in clinical characteristics, cardiac structure/function, invasive hemodynamics, and outcomes (eg, phenogroup 3 had an increased risk of HF hospitalization [hazard ratio, 4.2; 95% confidence interval, 2.0-9.1] even after adjustment for traditional risk factors [P<0.001]). The HFpEF phenogroup classification, including its ability to stratify risk, was successfully replicated in a prospective validation cohort (n=107). CONCLUSIONS: Phenomapping results in a novel classification of HFpEF. Statistical learning algorithms applied to dense phenotypic data may allow improved classification of heterogeneous clinical syndromes, with the ultimate goal of defining therapeutically homogeneous patient subclasses.
Authors: Yajuan Wang; Marc A Simon; Pramod Bonde; Bronwyn U Harris; Jeffrey J Teuteberg; Robert L Kormos; James F Antaki Journal: J Heart Lung Transplant Date: 2011-12-14 Impact factor: 10.247
Authors: Stuart J Pocock; Cono A Ariti; John J V McMurray; Aldo Maggioni; Lars Køber; Iain B Squire; Karl Swedberg; Joanna Dobson; Katrina K Poppe; Gillian A Whalley; Rob N Doughty Journal: Eur Heart J Date: 2012-10-24 Impact factor: 29.983
Authors: Anand Prasad; Jeffrey L Hastings; Shigeki Shibata; Zoran B Popovic; Armin Arbab-Zadeh; Paul S Bhella; Kazunobu Okazaki; Qi Fu; Martin Berk; Dean Palmer; Neil L Greenberg; Mario J Garcia; James D Thomas; Benjamin D Levine Journal: Circ Heart Fail Date: 2010-08-03 Impact factor: 8.790
Authors: Linda Ottoboni; Brendan T Keenan; Pablo Tamayo; Manik Kuchroo; Jill P Mesirov; Guy J Buckle; Samia J Khoury; David A Hafler; Howard L Weiner; Philip L De Jager Journal: Sci Transl Med Date: 2012-09-26 Impact factor: 17.956
Authors: Walter J Paulus; Carsten Tschöpe; John E Sanderson; Cesare Rusconi; Frank A Flachskampf; Frank E Rademakers; Paolo Marino; Otto A Smiseth; Gilles De Keulenaer; Adelino F Leite-Moreira; Attila Borbély; István Edes; Martin Louis Handoko; Stephane Heymans; Natalia Pezzali; Burkert Pieske; Kenneth Dickstein; Alan G Fraser; Dirk L Brutsaert Journal: Eur Heart J Date: 2007-04-11 Impact factor: 29.983
Authors: Orit Rozenblatt-Rosen; Rahul C Deo; Megha Padi; Guillaume Adelmant; Michael A Calderwood; Thomas Rolland; Miranda Grace; Amélie Dricot; Manor Askenazi; Maria Tavares; Samuel J Pevzner; Fieda Abderazzaq; Danielle Byrdsong; Anne-Ruxandra Carvunis; Alyce A Chen; Jingwei Cheng; Mick Correll; Melissa Duarte; Changyu Fan; Mariet C Feltkamp; Scott B Ficarro; Rachel Franchi; Brijesh K Garg; Natali Gulbahce; Tong Hao; Amy M Holthaus; Robert James; Anna Korkhin; Larisa Litovchick; Jessica C Mar; Theodore R Pak; Sabrina Rabello; Renee Rubio; Yun Shen; Saurav Singh; Jennifer M Spangle; Murat Tasan; Shelly Wanamaker; James T Webber; Jennifer Roecklein-Canfield; Eric Johannsen; Albert-László Barabási; Rameen Beroukhim; Elliott Kieff; Michael E Cusick; David E Hill; Karl Münger; Jarrod A Marto; John Quackenbush; Frederick P Roth; James A DeCaprio; Marc Vidal Journal: Nature Date: 2012-07-26 Impact factor: 49.962
Authors: Jennifer E Ho; Emily K Zern; Luke Wooster; Cole S Bailey; Thomas Cunningham; Aaron S Eisman; Kathryn M Hardin; Giovanna A Zampierollo; Petr Jarolim; Paul P Pappagianopoulos; Rajeev Malhotra; Matthew Nayor; Gregory D Lewis Journal: Circulation Date: 2019-05-28 Impact factor: 29.690
Authors: Sanjiv J Shah; Dalane W Kitzman; Barry A Borlaug; Loek van Heerebeek; Michael R Zile; David A Kass; Walter J Paulus Journal: Circulation Date: 2016-07-05 Impact factor: 29.690
Authors: Jacob P Kelly; Robert J Mentz; Alexandre Mebazaa; Adriaan A Voors; Javed Butler; Lothar Roessig; Mona Fiuzat; Faiez Zannad; Bertram Pitt; Christopher M O'Connor; Carolyn S P Lam Journal: J Am Coll Cardiol Date: 2015-04-28 Impact factor: 24.094
Authors: John H Newman; Stuart Rich; Steven H Abman; John H Alexander; John Barnard; Gerald J Beck; Raymond L Benza; Todd M Bull; Stephen Y Chan; Hyung J Chun; Declan Doogan; Jocelyn Dupuis; Serpil C Erzurum; Robert P Frantz; Mark Geraci; Hunter Gillies; Mark Gladwin; Michael P Gray; Anna R Hemnes; Roy S Herbst; Adrian F Hernandez; Nicholas S Hill; Evelyn M Horn; Kendall Hunter; Zhi-Cheng Jing; Roger Johns; Sanjay Kaul; Steven M Kawut; Tim Lahm; Jane A Leopold; Greg D Lewis; Stephen C Mathai; Vallerie V McLaughlin; Evangelos D Michelakis; Steven D Nathan; William Nichols; Grier Page; Marlene Rabinovitch; Jonathan Rich; Franz Rischard; Sharon Rounds; Sanjiv J Shah; Victor F Tapson; Naomi Lowy; Norman Stockbridge; Gail Weinmann; Lei Xiao Journal: Am J Respir Crit Care Med Date: 2017-06-15 Impact factor: 21.405
Authors: Manar D Samad; Alvaro Ulloa; Gregory J Wehner; Linyuan Jing; Dustin Hartzel; Christopher W Good; Brent A Williams; Christopher M Haggerty; Brandon K Fornwalt Journal: JACC Cardiovasc Imaging Date: 2018-06-13